Nuzenio

Mnpr

Mnpr news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Monopar Therapeutics (NASDAQ:MNPR) Upgraded at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:17:05 GMTBank of New York Mellon Corp Has $4.31 Million Position in Monopar Therapeutics Inc. $MNPR - MarketBeatMarketBeat · Fri, 07 Aug 2026 07:06:08 GMTMonopar Therapeutics (NASDAQ:MNPR) Sets New 1-Year High - What's Next? - MarketBeatMarketBeat · Thu, 06 Aug 2026 15:11:03 GMTMNPR Q2'26 Earnings: EPS estimate is (0.66) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:01:22 GMTMNPR Stock Rallies After Hours As Experimental Drug Shows Rapid Copper Balance Improvement In Genetic Disorder - StocktwitsStocktwits · Wed, 05 Aug 2026 09:44:03 GMTMNPR Q1 2026 Earnings: Narrower-than-Expected Loss Drives 6.73% Share Gain - Dividend Growth Analysis - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 05:38:22 GMTMonopar Therapeutics Inc (MNPR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKeyTradingKey · Sun, 26 Jul 2026 16:28:39 GMTMNPR Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Sentiment - Guidance Update - po-news-eg.netpo-news-eg.net · Sun, 26 Jul 2026 10:32:40 GMT

Timeline

Sat, 08 Aug 2026 06:17:05 GMTMonopar Therapeutics (NASDAQ:MNPR) Upgraded at Wall Street Zen - MarketBeat
Fri, 07 Aug 2026 07:06:08 GMTBank of New York Mellon Corp Has $4.31 Million Position in Monopar Therapeutics Inc. $MNPR - MarketBeat
Thu, 06 Aug 2026 15:11:03 GMTMonopar Therapeutics (NASDAQ:MNPR) Sets New 1-Year High - What's Next? - MarketBeat
Wed, 05 Aug 2026 11:01:22 GMTMNPR Q2'26 Earnings: EPS estimate is (0.66) USD - TradingView
Wed, 05 Aug 2026 09:44:03 GMTMNPR Stock Rallies After Hours As Experimental Drug Shows Rapid Copper Balance Improvement In Genetic Disorder - Stocktwits
Fri, 31 Jul 2026 05:38:22 GMTMNPR Q1 2026 Earnings: Narrower-than-Expected Loss Drives 6.73% Share Gain - Dividend Growth Analysis - dars.gov.et

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Mnpr.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.